GHRP-6 · Performance
GHRP-6 dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (100 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 62–84 mcg | 0.06–0.08 mL | 3–3 units0.02–0.03 mL | – |
| 60–75 kg / 132–165 lb | 77–103 mcg | 0.08–0.10 mL | 3–4 units0.03–0.04 mL | – |
| 75–90 kg / 165–198 lb | 94–126 mcg | 0.09–0.13 mL | 4–5 units0.04–0.05 mL | – |
| 90–105 kg / 198–231 lb | 111–150 mcg | 0.11–0.15 mL | 4–6 units0.04–0.06 mL | – |
| >105 kg / >231 lb | 128–173 mcg | 0.13–0.17 mL | 5–7 units0.05–0.07 mL | – |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for GHRP-6; the elapsed-time column is hidden.
GHRP-6 by goal
Read GHRP-6's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the GHRP-6 bibliography for relevance to dosing and pharmacokinetics.
- Changes in Locomotor Activity Observed During Acute Nicotine Withdrawal Can Be Attenuated by Ghrelin and GHRP-6 in Rats
- On the actions of the growth hormone-releasing hexapeptide, GHRP
- Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.